Echo, Good for you! That is quite an appreciati

Echo,

Good for you! That is quite an appreciation on GLSI and good news for breast cancer patients.

Cytodyn is targeting triple negative breast cancer, among others, not HERS2/ neu patients, so not competition to to leronlimab in this indication.